Arnold C Hanish
Director at Salarius Pharmaceuticals, Inc. (DCOY); Director at Omeros Corp (OMER)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$4K
Total bought / sold$4K / $282K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 28SEC | OMEROmeros Corp | Sell | 5,000 | $18.53 | $93K | +7.0% |
| Aug 28SEC | OMEROmeros Corp | Sell | 5,0005,000 held (−50%) | $18.88 | $94K | +5.0% |
| Aug 28SEC | OMEROmeros Corp | Sell | 5,000 | $19.02 | $95K | +4.3% |
| Jan 2SEC | DCOYSalarius Pharmaceuticals, Inc. | Sell | 155,000 held (−0%) | $0.64 | $10 | +129.7% |
| Jan 2SEC | DCOYSalarius Pharmaceuticals, Inc. | Sell | 12 | $0.64 | $8 | +129.7% |
| Nov 24SEC | DCOYSalarius Pharmaceuticals, Inc. | Buy | 5,0005,015 held (+33333%) | $0.75 | $4K | +96.0% |
- Sell
Director Arnold C Hanish sold $94K of OMER at $18.88 — cuts the stake by 50%.
- Buy
Director Arnold C Hanish bought $4K of DCOY at $0.75 — first open-market purchase in our records; raises the stake by 33333%.